Stirring the Talent Pool
Cell and gene therapies have earned a high profile in recent years, but the field’s rate of growth has led to a gold rush on talent. Widespread training initiatives and a supply of experienced professionals are vital to keep the industry moving forward.
Bruce Levine | | Longer Read
When people ask, “Do you teach?” I tell them that most of my teaching is actually outside of the University – and not only by virtue of our program here, but also through my position as President Elect of ISCT. There are many reciprocal invitations from collaborative societies around the world. In August, I was in Korea for a week, speaking at an innovation and biotechnology conference, and meeting biotech companies there. In March, I was in Taiwan, where I met with the Vice President at a conference. To be global, to engage, and to really move the needle forward as this technology progresses is an essential part of who we are as a society.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.